Ringoes, NJ, United States of America

Victor Mandla Moyo

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 2.6

ph-index = 10

Forward Citations = 227(Granted Patents)


Location History:

  • Concord, MA (US) (2014 - 2016)
  • Ringoes, NJ (US) (2016 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Carotenoid Compositions
Polyglutamated Antifolates
Combination Therapy
Targeted Liposomal Gemcitabine
Pancreatic Cancer Treatment
Alpha Polyglutamated Pemetrexed
Gamma Polyglutamated Methotrexate
Platinum Complexes
Cancer Treatment
ERBB3 Inhibitors
Triple Negative Breast Cancer
HER2-Positive Cancers
43 patents (USPTO):Explore Patents

Title: Victor Mandla Moyo: Innovator in Anticancer Therapies

Introduction

Victor Mandla Moyo, based in Ringoes, NJ, is an accomplished inventor with a remarkable portfolio of 31 patents. His innovative work primarily focuses on the development of compositions and methods for treating hyperproliferative disorders, such as cancer, utilizing advanced formulations.

Latest Patents

Among his latest contributions to the field are two notable patents:

1. **Gamma polyglutamated raltitrexed and uses thereof** - This patent discloses gamma polyglutamated raltitrexed compositions, including innovative delivery vehicles like liposomes encapsulating the gamma polyglutamated raltitrexed. It outlines methods for creating and utilizing these compositions in treating hyperproliferative conditions and immune system disorders, such as inflammation and autoimmune diseases like rheumatoid arthritis.

2. **Gamma polyglutamated antifolates and uses thereof** - Similar in focus, this patent discusses gamma polyglutamated antifolate formulations, specifically those containing liposomes filled with the antifolate. It provides insights into the manufacturing processes and application methods for treating similar disorders as mentioned in the first patent.

Career Highlights

Throughout his career, Victor Moyo has contributed significantly to pharmaceutical innovations, particularly during his tenure with L.E.A.F. Holdings Group LLC and Merrimack Pharmaceuticals, Inc. His expertise in drug formulation and delivery systems has propelled advancements in treating complex medical conditions.

Collaborations

Victor has collaborated with notable professionals in the industry, including Clet Niyikiza and Jonathan Basil Fitzgerald. These partnerships have fostered a collaborative environment conducive to innovative research and development in the pharmaceutical field.

Conclusion

Victor Mandla Moyo’s extensive patent portfolio and his focus on innovative therapies illustrate his commitment to advancing medical science. His work not only addresses critical health challenges but also positions him as a key figure in the ongoing evolution of cancer treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…